Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 6738-6742

  Keler, T ^a   Guyre, P M ^a   Vitale, L A ^a   Sundarapandiyan, K ^a   Van de Winkel, J G J ^a   Deo, Y M ^a   Graziano, R F ^a  

^a MEDAREX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; TUMOR VACCINE;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034671631     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.6738     Document Type: Article

References (30)

1. Antigen-macrophage interaction II Relative roles of cytophilic antibody and other membrane sites
2. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen
3. Targeted antigen presentation using cross-linked antibody heteroaggregates
4. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens
5. FcγRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes
6. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells
7. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells
8. The FcγRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR γ-chain
9. Role of B-cell and Fc receptors in the selection of T-cell epitopes
10. Enhanced antigen immunogenicity induced by bispecific antibodies
11. Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice
12. Cytotoxic antibodies trigger inflammation through Fc receptors
13. Fc receptors
14. IgG-mediated enhancement of antibody responses is low in Fc receptor γ chain-deficient mice and increased in FcγRII-deficient mice
15. Myeloma proteins as tumor-specific transplantation antigens
16. Idiotypic vaccination as a treatment for a B cell lymphoma
17. Idiotype vaccination against murine B cell lymphoma humoral and cellular requirements for the full expression of antitumor immunity
18. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response
19. A human FcγRI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics
20. Monoclonal antibodies that bind to distinct epitopes of FcγR are able to trigger receptor function
21. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies
22. Anti-idiotype antibodies can reduce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone
23. Complete molecular remission reduced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
24. Fc receptor-mediated binding and endocytosis by human mononuclear phagocytes monomeric IgG is not endocytosed by U937 cells and monocytes
25. Two distinct regions of FcγRI initiate separate signalling pathways revolved in endocytosis and phagocytosis
26. Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcγRI), blocks phagocytosis, and modulates receptor expression
27. Construction and characterization of a humanized anti-g-Ig receptor type I (FcγRI) monoclonal antibody
28. Cross-linking Fc receptors on monocytes triggers IL-6 production role in anti-CD3-induced T cell activation
29. Cross-linking of both FcγR1 and FcγRII reduces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-FcγR interactions functional activation of FcγRII by treatment with proteases or neuraminidase
30. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class 1-restricted antigen presentation after immune complex internalization